VERA
Vera Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -28.6% ·
Aktienfluss -7.7% ·
neue Nettopositionen -20.0%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | -2 | 39.21M | $1.68B | +6 | −8 |
| Q1 2026 | 88 | +8 | 35.14M | $1.43B | +11 | −3 |
| Q4 2025 | 79 | +2 | 37.37M | $1.89B | +2 | — |
| Q3 2025 | 14 | -1 | 22.48M | $653.29M | +1 | −3 |
| Q2 2025 | 13 | 0 | 19.02M | $448.09M | +1 | −1 |
| Q1 2025 | 10 | -4 | 8.70M | $208.98M | — | −4 |
| Q4 2024 | 14 | +2 | 9.43M | $398.65M | +2 | — |
| Q3 2024 | 11 | -1 | 7.58M | $334.97M | — | −1 |
| Q2 2024 | 12 | — | 7.20M | $260.63M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 4.75M | +8.6% | $114.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 4.75M | +8.6% | $114.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passiv) | 2.08M | +2.8% | $50.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 1.20M | +4.3% | $28.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.20M | +4.3% | $28.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 211.79K | +286.4% | $5.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 211.79K | +286.4% | $5.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Marshall Wace ✦ | 189.25K | -77.4% | $4.55M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Marshall Wace ✦ | 189.25K | -77.4% | $4.55M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Marshall Wace ✦ | 189.25K | -77.4% | $4.55M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 134.89K | +73.7% | $3.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (passiv) | 54.00K | +11.1% | $1.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 40.60K | +13.7% | $975,212 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 19.06K | +5.8% | $457,845 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Wellington Management ✦ | 19.06K | +5.8% | $457,845 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Wellington Management ✦ | 19.06K | +5.8% | $457,845 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 19.06K | +5.8% | $457,845 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 9.55K | -77.0% | $229,415 | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Adage Capital Partners | $20.30M | war 0.0% |
| Point72 Asset Management | $8.21M | war 0.0% |
| D. E. Shaw & Co. | $3.15M | war 0.0% |
| AQR Capital Management | $327,155 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 229 Inhaber, 72.17M Anteile, $2.73B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.